Analysis of Clinical, Serological, and Imaging Features of Autoimmune Pancreatitis and a Case-Control Study on Prognostic Factors in Response to Hormone Therapy

Table 2

Comparison of general information and clinical characteristics between the recurrent group and nonrecurrent group (n (%), ).

Index	N	Recurrent group (n = 42)	Nonrecurrent group (n = 64)	χ^2/t
Age	106	55.98 ± 9.25	56.13 ± 8.74	0.084	0.932
Gender
Male	78	30 (38.46)	48 (61.54)	0.166	0.683
Female	28	12 (42.86)	16 (57.14)
Course of disease (month)	106	4.19 ± 1.65	4.26 ± 1.87	0.197	0.844
BMI (kg/m^2)	106	25.53 ± 3.17	25.54 ± 4.83	0.011	0.990
Diabetes history
Yes	29	11 (37.93)	18 (62.07)	0.047	0.827
None	77	31 (40.26)	46 (59.74)
Jaundice
Yes	72	30 (41.67)	42 (58.33)	0.392	0.531
None	34	12 (35.29)	22 (64.71)
Abdominal pain
Yes	51	22 (43.14)	29 (56.86)	0.507	0.476
None	55	20 (36.36)	35 (63.64)
The stomach is swollen
Yes	36	17 (47.22)	19 (52.78)	1.316	0.251
None	70	25 (35.71)	45 (64.29)
Initial time of hormone therapy (month)	106	9.56 ± 2.53	15.72 ± 3.86	9.127	<0.001
Initial dose of hormone (mg)	106	39.28 ± 6.12	40.75 ± 7.11	1.098	0.274